HomeSPH • WSE
add
Sopharma AD
In the news
Financials
Income Statement
Revenue
Net income
| (BGN) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 637.00M | 28.75% |
Operating expense | 115.05M | 25.45% |
Net income | 30.07M | 86.27% |
Net profit margin | 4.72 | 44.79% |
Earnings per share | — | — |
EBITDA | 46.04M | 44.56% |
Effective tax rate | 12.49% | — |
Balance Sheet
Total assets
Total liabilities
| (BGN) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.55M | 31.10% |
Total assets | 1.97B | 33.21% |
Total liabilities | 1.05B | 58.34% |
Total equity | 926.37M | — |
Shares outstanding | 510.90M | — |
Price to book | 7.29 | — |
Return on assets | 3.67% | — |
Return on capital | 4.81% | — |
Cash Flow
Net change in cash
| (BGN) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 30.07M | 86.27% |
Cash from operations | -17.24M | -111.18% |
Cash from investing | -91.42M | -1,067.29% |
Cash from financing | 91.09M | 156.38% |
Net change in cash | -17.56M | -956.31% |
Free cash flow | -186.96M | -1,036.17% |
About
Founded
1933
Website
Employees
5,895
